首页> 外文OA文献 >Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

【2h】

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

机译：与未结合的不盲目的不良事件，但没有盲目的他汀类药物治疗，在盎格鲁 - 斯堪的纳维亚心脏成果试验 - 降低手臂（Ascot-LLA）：随机的双盲安慰剂对照试验及其非随机的非盲目延伸阶段

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Gupta A; Thompson D; Whitehouse A; Collier T; Dahlof B; Poulter N; Collins R; Sever P; ASCOT Investigators;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase [J] . Gupta Ajay, Thompson David, Whitehouse Andrew, The Lancet . 2017,第10088期

机译：与未结合的不盲目的不良事件，但没有盲目的他汀类药物治疗，在盎格鲁 - 斯堪的纳维亚心脏成果试验 - 降低手臂（Ascot-LLA）：随机的双盲安慰剂对照试验及其非随机的非盲目延伸阶段
2. Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA). [J] . Ostergren J Diabetes care . 2005,第5期

机译：阿托伐他汀在2,532例2型糖尿病患者中的心血管事件减少：盎格鲁-斯堪的纳维亚人的心脏结果降脂试验（ASCOT-LLA）。
3. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ran [J] . Sever PS, Dahlof B, Poulter NR, Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2004,第Suppla2期

机译：在盎格鲁-斯堪的纳维亚心脏结果试验-降脂臂（ASCOT-LLA）中，胆固醇水平平均或低于平均水平的高血压患者使用阿托伐他汀预防冠心病和中风事件：多中心
4. Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults and boosting of Malian adults with MVA-BN-Filo: a phase 1 single-blind randomised trial a phase 1b open-label and double-blind dose-escalation trial and a nested randomised double-blind placebo-controlled trial [O] . Milagritos D Tapia, Samba O Sow, Kirsten E Lyke, -1

机译：ChAd3-EBO-Z埃博拉病毒疫苗在马里和美国成年人中的使用以及用MVA-BN-Filo加强马来成年人的免疫：一项1期单盲随机试验1b期开放标签和双盲剂量递增试验以及嵌套随机双盲安慰剂对照试验
5. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase [O] . Gupta, A, Thompson, D, Whitehouse, A, 2017

机译：盎格鲁-斯堪的纳维亚心脏降脂试验组（ASCOT-LLA）中与未盲但未盲的他汀类药物治疗相关的不良事件：一项随机双盲安慰剂对照试验及其非随机，非盲扩展相

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

著录项

相似文献

相关主题

期刊订阅